105 related articles for article (PubMed ID: 11684446)
1. Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype.
Ramachandran S; Fryer AA; Lovatt T; Lear J; Smith AG; Strange RC
J Photochem Photobiol B; 2001 Oct; 63(1-3):1-7. PubMed ID: 11684446
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors determining cutaneous basal cell carcinoma phenotype.
Ramachandran S; Fryer AA; Strange RC
Med Pediatr Oncol; 2001 May; 36(5):559-63. PubMed ID: 11340612
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
Ramachandran S; Hoban PR; Ichii-Jones F; Pleasants L; Ali-Osman F; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Pharmacogenetics; 2000 Aug; 10(6):545-56. PubMed ID: 10975609
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma.
Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Griffiths CE; Jones PW; Strange RC
Cancer; 2000 Sep; 89(5):1012-8. PubMed ID: 10964331
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
[TBL] [Abstract][Full Text] [Related]
6. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck.
Ramachandran S; Fryer AA; Smith A; Lear J; Bowers B; Jones PW; Strange RC
Cancer; 2001 Jul; 92(2):354-8. PubMed ID: 11466690
[TBL] [Abstract][Full Text] [Related]
8. Genetics and risk factors for basal cell carcinoma.
Madan V; Hoban P; Strange RC; Fryer AA; Lear JT
Br J Dermatol; 2006 May; 154 Suppl 1():5-7. PubMed ID: 16712709
[TBL] [Abstract][Full Text] [Related]
9. Environment, phenotype and genetics: risk factors associated with BCC of the skin.
Hoban PR; Ramachandran S; Strange RC
Expert Rev Anticancer Ther; 2002 Oct; 2(5):570-9. PubMed ID: 12382525
[TBL] [Abstract][Full Text] [Related]
10. Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility.
Adolphe C; Xue A; Fard AT; Genovesi LA; Yang J; Wainwright BJ
Genome Med; 2021 Feb; 13(1):19. PubMed ID: 33549134
[TBL] [Abstract][Full Text] [Related]
11. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
[TBL] [Abstract][Full Text] [Related]
12. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.
Lear JT; Hoban P; Strange RC; Fryer AA
Clin Exp Dermatol; 2005 Jan; 30(1):49-55. PubMed ID: 15663504
[TBL] [Abstract][Full Text] [Related]
13. Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma.
Kosiniak-Kamysz A; Pośpiech E; Wojas-Pelc A; Marcińska M; Branicki W
J Dermatol; 2012 Aug; 39(8):693-8. PubMed ID: 22512251
[TBL] [Abstract][Full Text] [Related]
14. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
[TBL] [Abstract][Full Text] [Related]
15. Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy.
Lear JT; Smith AG; Strange RC; Fryer AA
Br J Dermatol; 2000 Jan; 142(1):8-15. PubMed ID: 10651688
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.
Heagerty AH; Fitzgerald D; Smith A; Bowers B; Jones P; Fryer AA; Zhao L; Alldersea J; Strange RC
Lancet; 1994 Jan; 343(8892):266-8. PubMed ID: 7905099
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
18. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
Lear JT; Smith AG; Bowers B; Heagearty AH; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
J Invest Dermatol; 1997 Apr; 108(4):519-22. PubMed ID: 9077484
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with the occurrence of basal cell carcinoma.
Simić D; Prohić A; Situm M; Zeljko Penavić J
Coll Antropol; 2010 Mar; 34 Suppl 1():147-50. PubMed ID: 20402311
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system.
Ramachandran S; Fryer AA; Lovatt TJ; Smith AG; Lear JT; Jones PW; Strange RC
Cancer Lett; 2003 Jan; 189(2):175-81. PubMed ID: 12490310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
